Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

The impact of the 2008/2009 financial crisis on specialist physician activity in Canada.

Lavergne MR, Hedden L, Law MR, McGrail K, Ahuja M, Barer M.

Health Econ. 2018 Jun 19. doi: 10.1002/hec.3786. [Epub ahead of print]

PMID:
29920841
2.

Assessing the perspectives of users and beneficiaries of a community health worker mHealth tracking system for mothers and children in Rwanda.

Musabyimana A, Ruton H, Gaju E, Berhe A, Grépin KA, Ngenzi J, Nzabonimana E, Hategeka C, Law MR.

PLoS One. 2018 Jun 7;13(6):e0198725. doi: 10.1371/journal.pone.0198725. eCollection 2018.

3.

Antibiotics use among Palestine refugees attending UNRWA primary health care centers in Jordan - A cross-sectional study.

Al Baz M, Law MR, Saadeh R.

Travel Med Infect Dis. 2018 Mar - Apr;22:25-29. doi: 10.1016/j.tmaid.2018.02.004. Epub 2018 Feb 16.

PMID:
29458088
4.

The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis.

Abimpaye M, Kirk CM, Iyer HS, Gupta N, Remera E, Mugwaneza P, Law MR.

PLoS One. 2018 Feb 16;13(2):e0192910. doi: 10.1371/journal.pone.0192910. eCollection 2018.

5.

The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.

Law MR, Cheng L, Kolhatkar A, Goldsmith LJ, Morgan SG, Holbrook AM, Dhalla IA.

CMAJ Open. 2018 Feb 5;6(1):E63-E70. doi: 10.9778/cmajo.20180008.

6.

Patterns of physician retirement and pre-retirement activity: a population-based cohort study.

Hedden L, Lavergne MR, McGrail KM, Law MR, Cheng L, Ahuja MA, Barer ML.

CMAJ. 2017 Dec 11;189(49):E1517-E1523. doi: 10.1503/cmaj.170231.

7.

Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study.

Skeldon SC, Cheng L, Morgan SG, Detsky AS, Goldenberg SL, Law MR.

J Sex Med. 2017 Dec;14(12):1597-1605. doi: 10.1016/j.jsxm.2017.10.063.

PMID:
29198514
8.

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Worthington HC, Cheng L, Majumdar SR, Morgan SG, Raymond CB, Soumerai SB, Law MR.

Implement Sci. 2017 Nov 25;12(1):141. doi: 10.1186/s13012-017-0671-z.

9.

Effect of incentive payments on chronic disease management and health services use in British Columbia, Canada: Interrupted time series analysis.

Lavergne MR, Law MR, Peterson S, Garrison S, Hurley J, Cheng L, McGrail K.

Health Policy. 2018 Feb;122(2):157-164. doi: 10.1016/j.healthpol.2017.11.001. Epub 2017 Nov 10.

10.

Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application.

Goldsmith LJ, Kolhatkar A, Popowich D, Holbrook AM, Morgan SG, Law MR.

Soc Sci Med. 2017 Dec;194:51-59. doi: 10.1016/j.socscimed.2017.10.007. Epub 2017 Oct 9.

PMID:
29065312
11.

Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.

Ngambi PG, Kalungia AC, Law MR, Kalemeera F, Truter I, Godman B, Munkombwe D.

Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):459-467. doi: 10.1080/14737167.2017.1364161. Epub 2017 Aug 11. Review.

PMID:
28770641
12.

Impact of a district-wide health center strengthening intervention on healthcare utilization in rural Rwanda: Use of interrupted time series analysis.

Iyer HS, Hirschhorn LR, Nisingizwe MP, Kamanzi E, Drobac PC, Rwabukwisi FC, Law MR, Muhire A, Rusanganwa V, Basinga P.

PLoS One. 2017 Aug 1;12(8):e0182418. doi: 10.1371/journal.pone.0182418. eCollection 2017.

13.

Impact of income-based deductibles on drug use and health care utilization among older adults.

Law MR, Cheng L, Worthington H, Mamdani M, McGrail KM, Chan FKI, Majumdar SR.

CMAJ. 2017 May 15;189(19):E690-E696. doi: 10.1503/cmaj.161119.

14.

Reply.

Kolhatkar A, Cheng L, Chan FKI, Harrison M, Law MR.

J Am Pharm Assoc (2003). 2017 May - Jun;57(3):298-299. doi: 10.1016/j.japh.2017.01.025. Epub 2017 Mar 6. No abstract available.

PMID:
28279598
15.

The authors respond to: letters by Catherine Clelland and Shelley Ross.

Lavergne MR, Law MR, Hurley J, McGrail K.

CMAJ. 2017 Feb 13;189(6):E251. doi: 10.1503/cmaj.732524. No abstract available.

16.

The Cardiovascular Safety of Dutasteride.

Skeldon SC, Macdonald EM, Law MR, Huang A, Paterson JM, Mamdani MM, Juurlink D.

J Urol. 2017 May;197(5):1309-1314. doi: 10.1016/j.juro.2016.11.082. Epub 2016 Nov 16.

PMID:
27866006
17.

A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease.

Lavergne MR, Law MR, Peterson S, Garrison S, Hurley J, Cheng L, McGrail K.

CMAJ. 2016 Oct 18;188(15):E375-E383. Epub 2016 Aug 15.

18.

The impact of medication reviews by community pharmacists.

Kolhatkar A, Cheng L, Chan FK, Harrison M, Law MR.

J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):513-520.e1. doi: 10.1016/j.japh.2016.05.002.

19.
20.

Sex-related Differences in Emergency Department Renal Colic Management: Females Have Fewer Computed Tomography Scans but Similar Outcomes.

Innes GD, Scheuermeyer FX, Law MR, McRae AD, Weber BA, Boyda HN, Lonergan K, Andruchow JE.

Acad Emerg Med. 2016 Oct;23(10):1153-1160. doi: 10.1111/acem.13041.

21.

Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections.

McKay R, Mah A, Law MR, McGrail K, Patrick DM.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4106-18. doi: 10.1128/AAC.00209-16. Print 2016 Jul. Review.

22.

Examining regional variation in health care spending in British Columbia, Canada.

Lavergne MR, Barer M, Law MR, Wong ST, Peterson S, McGrail K.

Health Policy. 2016 Jul;120(7):739-48. doi: 10.1016/j.healthpol.2016.04.007. Epub 2016 Apr 20.

PMID:
27131975
23.

The impact of policies to reduce blood glucose test strip utilization and costs in Canada.

Gomes T, Martins D, Cheng L, Kratzer J, Juurlink DN, Shah BR, Mamdani MM, Paterson JM, Law MR.

Can J Public Health. 2015 Apr 30;106(4):e210-6. doi: 10.17269/cjph.106.4788.

PMID:
26285192
24.

Erectile Dysfunction and Undiagnosed Diabetes, Hypertension, and Hypercholesterolemia.

Skeldon SC, Detsky AS, Goldenberg SL, Law MR.

Ann Fam Med. 2015 Jul-Aug;13(4):331-5. doi: 10.1370/afm.1816.

25.

The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.

Kratzer J, Cheng L, Allin S, Law MR.

Healthc Policy. 2015 May;10(4):62-74.

26.

Impact of allowing pharmacists to independently renew prescriptions: A population-based study.

Law MR, Cheng L, Kratzer J, Morgan SG, Marra C, Lynd LD, Majumdar SR.

J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):398-404. doi: 10.1331/JAPhA.2015.14262.

PMID:
26115380
27.

Blood pressure-lowering treatment should be based on the level of cardiovascular risk, not on the level of blood pressure.

Law MR.

Evid Based Med. 2015 Feb;20(1):21. doi: 10.1136/ebmed-2014-110102. Epub 2014 Dec 22. No abstract available.

PMID:
25534965
28.

The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis.

Skeldon SC, Kozhimannil KB, Majumdar SR, Law MR.

J Gen Intern Med. 2015 Apr;30(4):514-20. doi: 10.1007/s11606-014-3063-y. Epub 2014 Oct 23.

29.

The implications of the feminization of the primary care physician workforce on service supply: a systematic review.

Hedden L, Barer ML, Cardiff K, McGrail KM, Law MR, Bourgeault IL.

Hum Resour Health. 2014 Jun 4;12:32. doi: 10.1186/1478-4491-12-32. Review.

30.

Trends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009.

Sanmartin C, Hennessy D, Lu Y, Law MR.

Health Rep. 2014 Apr;25(4):13-7.

31.

The characteristics and fulfillment of conditional prescription drug approvals in Canada.

Law MR.

Health Policy. 2014 Jun;116(2-3):154-61. doi: 10.1016/j.healthpol.2014.03.003. Epub 2014 Mar 15.

PMID:
24703857
32.

The increasing inefficiency of private health insurance in Canada.

Law MR, Kratzer J, Dhalla IA.

CMAJ. 2014 Sep 2;186(12):E470-4. doi: 10.1503/cmaj.130913. Epub 2014 Mar 24. No abstract available.

33.

Cochrane report on lowering blood pressure.

Wald NJ, Law MR.

J Med Screen. 2014 Mar;21(1):3-4. doi: 10.1177/0969141314525368. No abstract available.

PMID:
24615473
34.

Comparability of self-reported medication use and pharmacy claims data.

Allin S, Bayoumi AM, Law MR, Laporte A.

Health Rep. 2013 Jan;24(1):3-9.

35.

Private expenditures on brand name prescription drugs after generic entry.

Balaban DY, Dhalla IA, Law MR, Bell CM.

Appl Health Econ Health Policy. 2013 Oct;11(5):523-9. doi: 10.1007/s40258-013-0052-y.

PMID:
23979876
36.

Cost-control mechanisms in Canadian private drug plans.

Kratzer J, McGrail K, Strumpf E, Law MR.

Healthc Policy. 2013 Aug;9(1):35-43.

37.

Money left on the table: generic drug prices in Canada.

Law MR.

Healthc Policy. 2013 Feb;8(3):17-25.

38.

Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

Puyat JH, Daw JR, Cunningham CM, Law MR, Wong ST, Greyson DL, Morgan SG.

Soc Psychiatry Psychiatr Epidemiol. 2013 Dec;48(12):1861-72. doi: 10.1007/s00127-013-0753-4. Epub 2013 Aug 14. Review.

PMID:
23942793
39.

The geographic accessibility of pharmacies in Nova Scotia.

Law MR, Heard D, Fisher J, Douillard J, Muzika G, Sketris IS.

Can Pharm J (Ott). 2013 Jan;146(1):39-46. doi: 10.1177/1715163512473062.

40.

Cesarean sections: the authors reply.

Kozhimannil KB, Virnig BA, Law MR.

Health Aff (Millwood). 2013 Jun;32(6):1171. doi: 10.1377/hlthaff.2013.0273. No abstract available.

PMID:
23733993
41.

The impact of high-deductible health plans on men and women: an analysis of emergency department care.

Kozhimannil KB, Law MR, Blauer-Peterson C, Zhang F, Wharam JF.

Med Care. 2013 Aug;51(8):639-45. doi: 10.1097/MLR.0b013e31829742d0.

42.

How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?

Allin S, Law MR, Laporte A.

Health Policy. 2013 May;110(2-3):147-55. doi: 10.1016/j.healthpol.2013.02.010. Epub 2013 Mar 19.

PMID:
23522381
43.

Cesarean delivery rates vary tenfold among US hospitals; reducing variation may address quality and cost issues.

Kozhimannil KB, Law MR, Virnig BA.

Health Aff (Millwood). 2013 Mar;32(3):527-35. doi: 10.1377/hlthaff.2012.1030.

44.

Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada.

Daw JR, Morgan SG, Thomson PA, Law MR.

Health Policy. 2013 Apr;110(1):67-75. doi: 10.1016/j.healthpol.2013.01.006. Epub 2013 Feb 16.

PMID:
23419420
45.

Growth in private payments for health care by Canadian households.

Law MR, Daw JR, Cheng L, Morgan SG.

Health Policy. 2013 May;110(2-3):141-6. doi: 10.1016/j.healthpol.2013.01.014. Epub 2013 Feb 16.

PMID:
23419418
46.

The road to competitive generic drug prices in Canada.

Law MR, Kratzer J.

CMAJ. 2013 Sep 17;185(13):1141-4. doi: 10.1503/cmaj.121367. Epub 2012 Nov 19. No abstract available.

47.

Drug development: Innovation or imitation deficit?

Morgan SG, Cunningham CM, Law MR.

BMJ. 2012 Sep 4;345:e5880. doi: 10.1136/bmj.e5880. No abstract available.

PMID:
22951558
48.

The essential and potentially inappropriate use of antipsychotics across income groups: an analysis of linked administrative data.

Puyat JH, Law MR, Wong ST, Sutherland JM, Morgan SG.

Can J Psychiatry. 2012 Aug;57(8):488-95.

PMID:
22854031
49.
50.

Geographic accessibility of community pharmacies in ontario.

Law MR, Dijkstra A, Douillard JA, Morgan SG.

Healthc Policy. 2011 Feb;6(3):36-46.

Supplemental Content

Support Center